Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Body weight”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9Linked to original sources
PubMed1978

Influence of a liquid diet and meal pattern on body weight and body fat in rats.

Rats weighing 110 to 150 g or 250 g initially were utilized in five experiments to determine the effect of the form of the diet (dry versus liquid) and the pattern of feeding (meal-feeding, force-feeding, nibbling, or ad libitum) on body weight gain and on body fat. A high-carbohydrate, 20% casein or 20% lactalbumin diet was fed for 4 to 8 weeks. Consumption of a diet mixed with an equal weight of water increased weight gain in one of three experiments. Body fat content of the rats was not influenced by addition of water to the diet. Neither force-feeding nor meal-feeding influenced body fat gain provided the respective control rats were pair-fed during the initial adaptation period. Likewise, when rats were pair force-fed to ad libitum fed rats without an initial adaptation meal frequency did not influence body fat gain. When meal-fed rats were switched to ad libitum intake their food intake increased to equal that of rats which had been continuously fed ad libitum; however, the rats which had been switched gained more body fat than did rats continuously fed ad libitum. These results suggest that meal frequency may have a minimal influence on body fat accumulation, but that a shift to a higher level of food intake may cause an increased food efficiency and greater rate of fat deposition than in rats continuously fed the higher level of intake.

Adipose Tissue↗
PubMed1996

Dehydroepiandrosterone in morbidly obese adolescents: effects on weight, body composition, lipids, and insulin resistance.

The hormone dehydroepiandrosterone (DHEA) has been reported to have beneficial effects on obesity, diabetes mellitus, and serum lipids in animal studies, but results in human studies are less clear. We conducted a randomized double-blind placebo-controlled trial to determine the effects of DHEA treatment on obesity and related physiologic conditions in adolescents and young adults. In this 10-week study, 13 morbidly obese subjects received a placebo for 2 weeks. After this run-in period, patients were randomized, with seven subjects (mean age, 15.5 years; body mass index [BMI, derived by dividing body weight in kilograms by height in meters squared], 48.2 +/- 9.7 [mean +/- SD]) receiving DHEA 40 mg sublingually twice daily for 8 weeks and six subjects (mean age, 18.0 years; BMI, 52.9 +/- 14) receiving placebo. Variables measured included body weight, body composition, resting metabolic rate (RMR), serum lipid levels, insulin sensitivity, and serum steroid levels. Treatment with DHEA resulted in a statistically significant increase in plasma DHEA and DHEA sulfate (DHEAS) concentrations (P < .01). Testosterone (T) levels were significantly increased in females who received DHEA. DHEA administration had no effect on body weight, sense of well-being, or any other measured variables. These findings suggest that DHEA 40 mg administered sublingually twice daily for 8 weeks has no positive effect on body weight, body composition, serum lipids, or insulin sensitivity in extremely obese adolescents and young adults.

Adolescent↗
PubMedDate not supplied

[Use of self-reported values of body weight and body height in nutritional status evaluation in adolescents].

INTRODUCTION: The aim of our study was to assess validity of self-reported body weight and height compared to measured values in a group of adolescents. We also investigated differences in reported and measured values and factors responsible for them in this particular population. MATERIAL AND METHODS: 295 adolescents aged 11-14 (114 boys and 131 girls) attending primary schools in central Belgrade, recorded their BMI and completed a series of questionnaires measuring body satisfaction and eating patterns. All participants were measured afterwards. RESULTS: Differences between reported and measured weights were highly significant in girls (48.84 +/- 8.42 kg vs 49.69 +/- 9.28 kg). Significant differences between reported and measured weights were established in the group of adolescents with weight problems (-3.18 +/- 4.03 kg). Adolescents on diets presented a difference of -1.36 +/- 3.36 kg. Weight problems (OR 3.72, 95%CI: 2.10-4.75) and female gender (errors occurred more often for 22%, 95%CI: 0.23-1.80) were significant predictors in multivariate regression model for discrepancy of reported and measured weights. In a multivariate regression model, where differences in BMI were dependent variable, weight category was a significant predictor, with differences being 1.65 times more common (95%CI: 1.13-2.11). DISCUSSION: Our results suggest that self-reported body weight and height have limited reliability and can be used only in normal weight male adolescents. This method should not be recommended in surveys that involve overweight and/or obese adolescents and those who are on diet.

Adolescent↗
PubMed1998

The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice.

Based on the findings that cholest-4-en-3-one, an intestinal metabolite of cholesterol, has an anti-obesity effect on animals, the structure-effect relationship of its 3-oxo derivatives and related compounds were investigated. Cholesten-3-ones, which possesses an enone structure with a carbonyl group at C3, markedly inhibit body weight gain and body fat accumulation, as well as the levels of serum triglyceride and cholesterol in animals without any clinical abnormalities.

Adipose Tissue↗
PubMedDate not supplied

Interspecies scaling: predicting clearance of anticancer drugs in humans. A comparative study of three different approaches using body weight or body surface area.

From this study it is proposed that the clearance of anti-cancer drugs may be best estimated if they follow the following trend: (i) that if the exponent of the allometric equation (clearance vs body weight) lies between 0.55-0.75 (0.75 was chosen after Kleiber's power rule (18)), then a simple allometric equation can predict the clearance reasonably well; (ii) if the exponent of the allometric equation lies between 0.75 to approximately 0.90, clearance can be reasonably predicted using CL x MLP; and (iii) if the exponent of the allometric equation is > or = 0.90, the clearance can be predicted using the product of clearance and brain weight.

Animals↗
PubMed1999

Impact of lactation on maternal body weight and body composition.

Women worldwide generally lose weight and body fat during lactation. This loss, although increased by longer, more intensive breastfeeding, is modest and may be reduced by increased food intake and decreased activity. Higher parity and older age are associated with greater weight loss postpartum among poorly nourished women. Well-nourished women or those who breastfeed only for a limited time may not return to their prepregnant weight or body composition by the end of the lactation period. Those who are overweight or obese may have difficulty initiating or maintaining lactation. For the majority of women in the world, lactation is unlikely to represent a threat to their health. To advise women on how to optimize their health and lactational performance, one must consider all of the changes in maternal nutritional status that occur during a reproductive cycle, which may or may not compensate for the modest decreases in body weight associated with lactation.

Body Composition↗
PubMed1996

Weight, body composition, and bone density in postmenopausal women.

Associations of body weight and body composition with bone mineral density (BMD) were examined in 261 postmenopausal women. BMD, body fat, and body nonfat soft tissue (NFST) were measured by dual-energy X-ray absorptiometry (DXA). A height-independent BMD variable (HIBMD) was calculated to correct for differences among individuals in bone thickness, a dimension that is ignored by DXA scanners. HIBMD was calculated as BMD divided by height at the spine and femoral neck, and BMD divided by the square root of height at the total body. Weight, fat, and nonfat soft tissue were all positively correlated with both BMD and HIBMD, but the magnitudes of regression and correlation coefficients were lower when HIBMD was the dependent variable. The weight-independent associations of body composition with HIBMD were examined by including weight and % NFST together in linear models. In these analyses, weight was positively associated with HIBMD at all three skeletal sites (r = 0.22-0.26, P < 0.05), % NFST was not associated with HIBMD at the spine or femoral neck (r = 0.01-0.02), and there was only a weak inverse correlation of % NFST with total body BMD (r = -0.12, P < 0.05). These findings are consistent with those of previous studies demonstrating positive associations between body weight and BMD. In addition, they demonstrate that once bone thickness and body weight are taken into account, body composition appears to have little if any independent effect on bone density at the skeletal sites measured. This finding is consistent with the hypothesis that the protective effect of body weight is brought about predominantly through its mechanical force on the skeleton.

Aged↗
PubMed1997

Estimation of body weight from body size measurements and body condition scores in dairy cows.

The objective of this study was to evaluate the use of hip height and width, body condition score, and relevant demographic information to predict body weight (BW) of dairy cows. Seven regression models were developed from data from 972 observations of 554 cows. Parity, hip height, hip width, and body condition score were consistently associated with BW. The coefficients of multiple determination varied from 80 to 89%. The number of significant terms and the parameter estimates of the models differed markedly among groups of cows. Apparently, these differences were due to breed and feeding regimen. Results from this study indicate that a reliable model for estimating BW of very different dairy cows maintained in a wide range of environments can be developed using body condition score, demographic information, and measurements of hip height and hip width. However, for management purposes, substantial improvements can be obtained by developing models that are specific to a given site.

Animals↗
PubMed2005

Adjusted body weight, con: why adjust body weight in energy-expenditure calculations?

Evaluation of energy requirements of normal individuals and hospitalized patients is most often accomplished using an energy equation. Energy equations attempt to measure resting metabolic rate (RMR), the largest factor in total daily energy expenditure. Components of most energy equations include height, weight, age, and gender. These factors are related to energy expenditure; however, each factor has individual characteristics that affect energy expenditure. Body weight is a major factor in RMR and total daily energy expenditure. For obese individuals, estimation of energy expenditure may be a challenge due to the increased body weight. Therefore, some equations attempt to minimize the effect of body weight on energy expenditure assessment by adjusting the obese individual's body weight. Data do not support adjustment of body weight in normal individuals. In hospitalized patients, there are several equations that are used to estimate energy expenditure of obese patients, which include adjusting the body weight and modifying the overall energy requirements. Measurement of RMR can obviate the need for estimating energy expenditure. It is important to evaluate any energy-expenditure equation that is used to estimate energy needs in normal people and hospitalized patients before applying it to patient care.

Basal Metabolism↗
PubMed2000

Effect of topiramate on body weight and body composition of osborne-mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncoupling-protein mRNAs.

The effects of topiramate on food intake and body composition were investigated in rats fed a high-fat diet and compared with rats that were pair fed or treated with D-fenfluramine. Topiramate (40 mg. kg. d for 80 d) reduced body-weight gain in a manner similar to that of pair-fed rats and D-fenfluramine-treated rats. The reduction in body fat accounted for all the weight reduction after topiramate treatment but not after pair feeding or D-fenfluramine treatment. Topiramate reduced food intake acutely and increased metabolic rate. There were also significant reductions in leptin, insulin, and corticosterone. In the hypothalamus, topiramate increased mRNA for neuropeptide Y, reduced mRNA for neuropeptide-Y Y1 and Y5 receptors, corticotropin-releasing hormone (CRH), and type II glucocorticoid receptors but had no effect on mRNA levels for the short or long form of the leptin receptor. In peripheral tissues, topiramate reduced leptin mRNA in adipose tissue, had no effect on uncoupling protein 1 mRNA in brown adipose tissue but had tissue-selective effects on uncoupling proteins 2 and 3 mRNA levels in white and brown adipose tissues and muscle. In conclusion, topiramate is an effective inhibitor of weight gain in rats on a high-fat diet, but the mechanism through which the change in energy balance is achieved is unclear.

Animals↗
PubMed1998

Body weight and body composition changes after treatment of hyperthyroidism.

Body composition changes in nine adults with hyperthyroidism were determined with dual energy x-ray absorptiometry and computed tomography at diagnosis and after 3 and 12 months of euthyroidism achieved by surgery, antithyroid drugs, or treatment with radioiodine. Mean body weight was 67.6 kg at diagnosis and increased 2.7 kg (P=0.06) and 8.7 kg (P < 0.001) after 3 and 12 months of euthyroidism, respectively. Basal metabolic rate decreased from 2087 Cal/24 h at diagnosis to 1601 Cal/24 h at 12 months (P=0.001), whereas reported energy intake dropped from 3244 to 2436 Cal/24 h (P=0.01). According to dual energy x-ray absorptiometry, body fat was unchanged at 3 months, but increased by 5.3 kg (P < 0.0001) at 12 months. Fat-free mass increased 2.7 kg (P=0.003) at 3 months and 3.5 kg (P < 0.0001) at 12 months. Changes in bone mineral content and density did not reach significance. According to computed tomography, skeletal muscle plus skin areas increased by 11% (trunk) and 18% (thigh) at 3 months and by 17% (trunk) and 25% (thigh) at 12 months. There was no increase in sc adipose tissue (AT) at 3 months, but at 12 months this AT depot increased by 15% (thigh) and 33% (trunk). Intraperitoneal AT showed a borderline significant increase by 28% (P=0.08) at 3 months and by 40% (P=0.015) at 12 months. Areas of visceral organs and bone tissue of femur did not change significantly during the study. It is concluded that during early recovery from hyperthyroidism, priority is given to the replenishment of skeletal muscles and ip AT, whereas sc AT is increased at a later stage.

Absorptiometry, Photon↗
PubMed1995

Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study.

OBJECTIVE: To evaluate the effects of hormone replacement therapy (HRT) on body weight and composition, fat distribution, and food intake in women entering the climacteric. DESIGN: Prospective clinical study. SETTING: Outpatient menopause clinic at a tertiary medical center. PARTICIPANTS: Sixty-three early postmenopausal women (44 to 54 years old) were prospectively studied for 1 year. They consisted of two groups: group A, 34 subjects who initiated continuous estrogen and progestin treatment (daily oral conjugated estrogen 0.625 mg and medroxyprogesterone acetate 2.5 mg), and group B, 29 women who refused hormonal therapy and served as controls. The age, menopausal status, initial anthropometric measurements (weight, body mass index [BMI], fat mass, and waist-to-hip girth ratio), and daily food intake (total caloric intake and food composition) were similar in both groups. INTERVENTIONS: Anthropometric measurements were performed before commencement of HRT use and after 12 months. MAIN OUTCOME MEASURES: Anthropometric measurements included BMI, waist-to-hip girth ratio, and body composition (the percentage of body fat and water) estimated by means of infrared interactance. Daily food intake was also recorded. RESULTS: The body weight and fat mass increased significantly in both the treatment (73.22 +/- 2.01 [mean +/- SE] to 75.57 +/- 1.12 kg) and the control group (71.45 +/- 3.11 to 73.51 +/- 1.23 kg). However, a significant shift from gynoid to android fat distribution was observed only in the control group (waist-to-hip ratio shifted from 0.80 +/- 0.01 to 0.85 +/- 0.01), whereas no significant change was observed in the treatment group (0.81 +/- 0.01 to 0.82 +/- 0.01). Caloric and macronutrient intake did not change in either group. CONCLUSIONS: These results indicate that continuous daily estrogen and progestin replacement therapy neither prevents nor increases early postmenopausal weight gain and fat accumulation. However, it does minimize the shift from gynoid to android fat distribution.

Adult↗
PubMed1984

The influence of photoperiod on body weight gain, body composition, nutrient intake and hormone secretion.

Increasing daily light exposure from 8 to 16 h increases average daily body weight gains of sheep and Holstein cattle but reduces gains of white-tailed doe fawns. Some of these effects on average daily gain in sheep are the result of increased gut fill and pelt weight. Increasing daily exposure to light increases feed intake when sheep or cattle are fed ad libitum. However, increased feed intake is not a prerequisite for the anabolic effects of long duration exposures to light because increased growth occurs in the animals given 16 h light:8 h dark (16L:8D) even when feed intake is restricted. The anabolic effects of increased duration photoperiods in sheep are independent of the gonads, whereas in cattle they are dependent on the gonads. Consistent increases in average daily gains of cattle in response to longer duration photoperiods have not always been achieved. The lack of consistency may be associated with sexual maturity or rate of fattening of the animal. For example, the stimulatory effects of 16L:8D photoperiods on live weight gain are not readily manifested in immature prepubertal heifers, but occur primarily during the peripubertal period. Short days are conducive to deposition of fat, which may account for the stimulatory effects of short days on live weight gain of white-tailed doe fawns and excessively fattened Holsteins. In contrast, long duration photoperiods stimulate protein accretion in cattle. The hormonal signals that mediate the anabolic effects of increasing exposure to light are not associated with change in insulin, thyroxine or growth hormone concentrations in the blood. Glucocorticoid concentrations in serum decrease with longer duration photoperiods which is consistent with an anabolic effect. Increasing daily light exposure to 16 h/d hastens the increase in concentrations of progesterone and testosterone in sera of peripubertal heifers and prepubertal bulls, respectively. Thus, change in secretion of reproductive hormones in the peripubertal period of cattle may be associated with the anabolic effects previously described and is consistent with gonad dependency. Prolactin concentrations in serum increase in sheep and cattle as duration of light exposure increases. But, there is no irrefutable proof that prolactin is responsible for the increased rates of gain or change in carcass composition associated with longer exposures to light. Thus, the hormonal mechanisms involved in photoperiod-induced alterations in growth remain to be established.

Adipose Tissue↗